Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1017 per EA under NDC 23155065101. Its NADAC has been published 448 times since Mar 7, 2018.
FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155065101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205245FDA Approved
9/23/2015
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 448 times since Mar 7, 2018, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1017 per EA |
|---|---|
| All-time high | $0.2243 (Apr 11, 2018) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1070 |
| 52-week low | $0.0623 |
| Median price | $0.1196 |
| Average price | $0.1284 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 448 |
| Tracking since | Mar 7, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METRONIDAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.1017 per EA (NDC 23155065101), effective Sep 30, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 53.3%. It has been tracked across 448 weekly CMS publications since Mar 7, 2018.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Mar 7, 2018, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.2243 (Apr 11, 2018), with a median of $0.1196 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 23155065101) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.